trial
as of 2026-07-01Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients With Schizophrenia
NCTId NCT00981526
at a glance
Phase 4 · Completed
Enrollment 66 (actual)
Sponsored by University of Massachusetts, Worcester
Primary completion 2012-05
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Completed
Enrollment
66 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2009-03
Primary completion
2012-05
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
University of Massachusetts, WorcesterLead Sponsor
National Institutes of Health (NIH)Collaborator
Investigators
1
Xiaoduo Fan, MD, MPH, MSPrincipal Investigator
Sites
1 total
Worcester, United States
Facts & assertions
4 sourced
Enrollment
66
Phase
PHASE4
Primary Completion Date
2012-05
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
collaborator
indication
investigator
person